These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4136394)

  • 41. Studies on the role of fibrinolysis and fibrinogen degradation products (FDP) in analgesic action of morphine.
    Buczko W; Wiśniewski K
    Thromb Diath Haemorrh; 1972 Dec; 28(3):359-66. PubMed ID: 4265317
    [No Abstract]   [Full Text] [Related]  

  • 42. [On euglobulin fibrinolysis. III. Primary data on the characteristics of euglobulin fibrinolysis in infective diseases and in neoplasms].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1375-6. PubMed ID: 13807118
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on activator formation in human plasma with streptokinase. I. Experimental studies.
    Martin M
    Thromb Diath Haemorrh; 1973 Nov; 30(2):381-92. PubMed ID: 4773377
    [No Abstract]   [Full Text] [Related]  

  • 44. [The studies on the method of euglulin clot lysis time using acid-treated euglobulin (author's transl)].
    Yasukouchi T; Yoshida S; Watanabe T; Fujine M; Kohn S; Morioka T; Sakurama S; Nakagawa S
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):553-8. PubMed ID: 696195
    [No Abstract]   [Full Text] [Related]  

  • 45. Streptokinase in the isolated perfused liver.
    Losito R; Lemieux E
    Am J Physiol; 1974 Aug; 227(2):477-81. PubMed ID: 4277668
    [No Abstract]   [Full Text] [Related]  

  • 46. [TESTS FOR THE DETECTION OF THE ACTIVITY OF FIBRINOLYTIC ENZYMES].
    PAPAPANAGIOUTOU PT
    Delt Hell Mikrobiol Hygieinol Hetair; 1963; 8():161-6. PubMed ID: 14091264
    [No Abstract]   [Full Text] [Related]  

  • 47. [Endogenous and exogenous fibrinolysis].
    Perlick E; Wilfert K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):28-32. PubMed ID: 4189368
    [No Abstract]   [Full Text] [Related]  

  • 48. Assay of urokinase inhibitor in plasma euglobulin.
    Lauritsen OS
    Scand J Clin Lab Invest Suppl; 1967; 100():27. PubMed ID: 6068385
    [No Abstract]   [Full Text] [Related]  

  • 49. [EFFECTS ON FIBRINOLYTIC ACTIVITY OF TOLBUTAMIDE ADDED "IN VITRO" TO PLASMA AND TO THE EUGLOBULIN FRACTION].
    BELLI C; TESSARI L
    Arch Sci Med (Torino); 1963 Oct; 116():181-7. PubMed ID: 14098152
    [No Abstract]   [Full Text] [Related]  

  • 50. Interaction of human plasminogen with deoxyribonucleic acids. II. Protection of human plasminogen against catalytic activation with deoxyribonucleic acids.
    Hakim AA
    Enzymologia; 1970 Jan; 38(1):57-81. PubMed ID: 4244649
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on fluidity of blood on the basis of fibrinolysis. 8. Analysis of fibrinolytic activity of the human blood activated with streptokinase and urokinase in vitro--with special reference to its similarity to fibrinolytic activity of fluid corpse blood.
    Ishizu H; Nobuhara M; Takata H
    Nihon Hoigaku Zasshi; 1971 Sep; 25(3):366-72. PubMed ID: 5167453
    [No Abstract]   [Full Text] [Related]  

  • 52. Euglobulin fibrinolysis in newborn infants, healthy prematures, and prematures with respiratory distress syndrome (R.D.S.).
    Arustowicz Z
    Ann Paediatr; 1966; 206(4):265-75. PubMed ID: 6012739
    [No Abstract]   [Full Text] [Related]  

  • 53. [Leukocytes and fibrinolysis. II. Study of pathological leukocytes].
    Tatarsky I; Sinakos Z; Larrieu MJ; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(1):95-107. PubMed ID: 4226638
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies of the fibrinolytic system in vitro and in vivo.
    Menon S
    Lab Pract; 1968 Aug; 17(8):898-900 contd. PubMed ID: 5671710
    [No Abstract]   [Full Text] [Related]  

  • 55. Plasma heparin-precipitable fraction in leprosy patients.
    Meyers WM
    Int J Lepr Other Mycobact Dis; 1968; 36(2):192-202. PubMed ID: 5691831
    [No Abstract]   [Full Text] [Related]  

  • 56. [Euglobulin lysis time].
    Ohta S; Sakuragawa N
    Nihon Rinsho; 1999 Sep; 57 Suppl():546-7. PubMed ID: 10543173
    [No Abstract]   [Full Text] [Related]  

  • 57. An evaluation of the euglobulin method for the determination of fibrinolysis.
    KOWALSKI E; KOPEC M; NIEWIAROWSKI
    J Clin Pathol; 1959 May; 12(3):215-8. PubMed ID: 13654539
    [No Abstract]   [Full Text] [Related]  

  • 58. [The euglobulin system of the blood serum. VI. Diagram of serum euglobulin solubility in the dog].
    WESLEY I; STEFANOVIC M
    Acta Med Iugosl; 1960; 14():204-7. PubMed ID: 13784540
    [No Abstract]   [Full Text] [Related]  

  • 59. SUPPLEMENTARY NOTE ON THE EUGLOBULIN FRACTION METHOD AS TOOL OF CLINICAL PLASMIN RESEARCH.
    MAKI M
    Tohoku J Exp Med; 1963 Nov; 81():179-87. PubMed ID: 14083617
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the modifications of euglobulin fibrinolysis induced after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1500-2. PubMed ID: 13807123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.